MICROMYCETES INFECTION IN PATIENTS WITH THERMAL TRAUMA
Authors:
B. Lipový 1,2; J. Holoubek 1; H. Řihová 1; Y. Kaloudová 1; M. Hanslianová 3; M. Cvanová 4; J. Jarkovský 4
; I. Suchánek 1; P. Brychta 1,2
Authors place of work:
Department of Burns and Reconstructive Surgery, University Hospital Brno, Czech Republic
1; Medical Faculty, Masaryk University, Czech Republic
2; Department of Clinical Microbiology, University Hospital Brno, Czech Republic
3; Institute of Biostatistics and Analyses, Medical Faculty, Masaryk Universit, Czech Republic
4
Published in the journal:
ACTA CHIRURGIAE PLASTICAE, 59, 1, 2017, pp. 27-32
INTRODUCTION
Severely and critically burned patients are exposed every day to a wide range of potentially pathogenic microorganisms (PPM).1 Infectious complications represent a predominant cause of mortality in these patients. This fact is mainly due to improved quality of care for these patients, when patients who would certainly die many years ago can survive an extensive thermal trauma today. Another reason is also increasing resistance of potentially pathogenic microorganisms.2 Recently we also noticed change in the occurrence of each PPM in the patients with thermal trauma. Bacteria are still the predominant PPM in these patients, however especially micromycetes infections play an important role today as well.3
This is mainly due to extensive loss of skin cover, or compromised function of skin as a barrier and local immunologic function. An important factor is also the fact that severe and critical burns are associated with a decline of immunological performance with a character of immune paralysis to immunosuppression. Antibacterial strategies and also antibiotics lead to selection of resistant forms of bacteria and they also facilitate propagation of yeasts and fungi.4
MATERIAL AND METHODS
This is a retrospective monocentre study, which enrolled all burn patients over the age of 18 with a thermal trauma who were hospitalized at the Department for Burns and Reconstructive Surgery of the University Hospital Brno within the period from 01/01/2007 to 31/12/2015. Yeasts or fibrous fungi were demonstrated in cultures in all of the patients in the group during hospitalization. Basic epidemiological markers were evaluated in these patients. ABSI score (Abbreviated Burn Severity Index) was used to determine the degree of the thermal trauma.
Culture of yeasts and fungi
Biological material sent for culture examination is processed according to the sample character. Culture on blood agar and MacConkey agar is a standard examination for all types of biological material; they represent the basic media for culture examination. Other selective culture media with a higher content of sodium chloride are subsequently added according to the sample character to demonstrate Staphylococci, VL agar is added to demonstrate anaerobic bacteria, etc. Microscopic preparation belongs to a standard for liquid materials; some of them are processed quantitatively (bronchoalveolar lavage, sputum, urine).
In case of a suspicious micromycetes infection, cultivation on standard media is supplemented with inoculation of material on mycological media: the most frequently used medium is Sabouraud agar. Biological material is inoculated on Sabouraud agar on Petri dishes and on several inclined Sabouraud agars in a tube intended for growth of fibrous fungi. Cultivation takes place for 7 days and under a temperature of 28–30°C for yeasts. Fibrous fungi are cultured in room temperature and simultaneously under thermostat temperature of 35–37°C. Growth on a chromogenic medium is used to determine the type of grown yeasts (colour change), production of chlamydospores during a growth on rice agar and weight spectrometry-MALDI-TOF. Fibrous fungi are classified into a genus and species based on their macroscopic appearance and microscopic preparation from the culture.
Statistical analysis
Continuous and ordinal parameters are described in tables with mean, median, minimum and maximum. Categorical variables are described as a number of patients and their relative count in given groups. The results of statistical evaluation are presented as p-values of statistical tests. Mann-Whitney test is used, when continuous or ordinal parameters are compared between two groups of patients. Fisher’s exact test is used to examine the association between two categorical variables. Statistically significant results at significance level 0.05 (p-value <0.05) are provided in bold. For all statistical analysis IBM SPSS Statistics ver. 23 (IBM Corporation, 2015) was used.
RESULTS
There were 61 patients with thermal trauma in whom yeast or fibrous fungi were isolated during the period of observation. There were 37 males and 24 females (M:F ratio – 1.5:1) in the group. Average age of the patients was 57.3 years (29 patients below 60 years of age, 32 patients were over 60 years, inclusive). 6 patients died (mortality was 9.8%). The average extent of the burn area was 21.6% TBSA (median 14.0%). There were 21 patients with severe thermal trauma, i.e. with an extent of the burn over 20% TBSA; there were 12 patients with a critical burn (extent of the burn over 40% TBSA). Average value of ABSI was 7.9. The highest number of the patients in the group was 5-8 within the ABSI range (39 patients, 63.9%). The basic epidemiological data of the patients in the monitored group are provided in Table 1.
There were 90 strains of micromycetes obtained from cultures in total in these patients (79 yeasts, 11 fibrous fungi). Micromycetes were isolated from burn area in 30 patients, from the lower airways in 19 patients, from the urogenital area in 15 patients and from blood culture in 7 patients. Non-albicans Candida strains were predominant among yeasts (60 species), Candida albicans was isolated totally 16 times. Aspergillus fumigatus (4 isolations) and Fusarium species (2 isolations) were predominant species among fibrous fungi. All of the isolated strains of yeasts and fibrous fungi are shown in the Table 2.
Micromycetes were obtained from culture in 7 patients in total within the first 5 days of hospitalization (11.5%). The number of patients with micromycetes isolation increased during further course. Micromycetes were cultured in 15 patients during the 6th - 10th day of hospitalization (25.0%), in 8 patients during the 11th–5th day (14.0%) and in 33 patients (61.1%) after the 16th day of hospitalization. The evaluation of the extent of thermal trauma expressed by the ABSI value is also interesting including its influence on the risk of micromycetes infection development. Within the 10th day of hospitalization the patients with positive culture for yeasts or fungi have a lower ABSI value than patients without positive culture. Higher ABSI value contributes on the development of infection caused by micromycetes until the 11th day of hospitalization. The effect of ABSI on the risk of yeast or fungi infection development is shown in Table 3.
During the monitoring of the effect of particular risk factors on the development of multipathogenic micromycetes infection in the patients from our group, we could not identify any of the factors with a statistically significant effect. In spite of that is interesting the effect of gender, while infectious complications in females were more frequent (p=0.093) or the effect of burn area extent (p=0.244). The most important risk factors for multipathogenic micromycetes infection are shown in Table 4.
Other risk factors for the development of infectious complications in the specific localisation are shown in Tables 5 and 6.
A strong effect of mechanical ventilation or tracheostoma (p<0.001, and p<0.001 respectively) was demonstrated from the infection development point of view in the area of the lower airways, when micromycetes were also isolated from the material. However, it is also interesting that tracheostoma and artificial pulmonary ventilation represent a risk factor for the development of micromycetes infection only in patients over the age of 60. This risk is not statistically significant in younger patients. Verification of inhalation trauma itself is close above the margin of statistical significance (p=0.053). On the contrary, the effect of mechanical ventilation duration was not shown as important for isolation of yeasts or fungi from the area of the lower airways (p=0.581).
Micromycetes was most frequently isolated from burn area. In spite of that, we could not demonstrate any significant effect on the development of infection in this localisation in any of the monitored parameters, even if the values were close to statistical significance in case of absence of a deep burn or extent of the burn over 40% TBSA (p=0.053, and 0.059, respectively).
DISCUSSION
Even today, infectious complications represent a predominant cause of mortality and morbidity of burn patients. Burns represent such type of trauma, in which development of opportune infections may be very common. Paradoxically, the increase of infectious complications caused by micromycetes is due to extensive therapeutic approach in local and also systemic control of bacterial infection. Especially topical antibacterial dressing started the rising incidence of mycotic infections, which continues until today.6 Candida infections are predominant in burn patients. The incidence of non-Candida infectious complications is much lower, however this fact is observed also in other groups of critically ill patients. 7,8
Infection of the burn area is the most common location with regards to the occurrence of infectious complications in burn patients, no matter whether this is a bacterial or non-bacterial aetiological agent. Fungi are not predominant pathogens in the development of burn area infection, however their contribution gradually rises. Burn area infected with Candida albicans is shown on Figure 1.
According to a retrospective study of the American Burn Association (ABA), micromycetes were demonstrated as an aetiological agent in 6.3% of all infectious complications in the burn area.9 Contribution of micromycetes in the aetiology of burn area infection reaches much higher values (20–40%) in most studies.10,11 Questionable remains the real incidence. With regards to a common absence of specific clinical symptoms, omission of micromycetes role in burn patients or difficult laboratory diagnostics, the infectious complication may be missed in several patients. In relation to the incidence of infectious complications caused by fungi in burn patients, it is not possible to demonstrate whether there is a clear geographic prerequisite. This fact is due to worldwide presence of micromycetes.12
Isolation of Candida albicans within monitoring of each micromycetes is currently predominant in most of studies. Very surprising finding in our group of patients is that occurrence of non-albicans Candidas is much higher than the count of isolated Candida albicans strains. Count of the isolated Candida krusei and Candida glabrata strains is also alarming with regards to the sensitivity to the most commonly available antimycotic drug at present. Both these yeasts are virtually resistant to fluconazole (Candida krusei is naturally resistant, Candida glabrata acquires resistance very quickly). Another option for therapy of infection caused by these micromycetes is administration of echinocandins. Therefore occurrence of these yeasts means always a dramatic increase of economic costs of therapy. Most studies identify the basic risk factors for the development of candidemia, and possibly candidiasis. Greater extent of the burn area, prolongation of the period from trauma to admission, presence and extent of deep burns, number of surgical procedures, total parenteral nutrition or therapy with antibiotics (cotrimoxazole, amikacin, vancomycin and other) are such risk factors.12 We focused on the two most common locations in our group with regards to the development of mycotic infection, i.e. on the burn area and lower airways. In case of burn area, no risk factor that would significantly contribute on the development of infection was demonstrated, although the extent of burn area and absence of a deep burn are on the margin of statistical significance. In case of infectious complication development in the area of the lower airways, the presence of a tracheostoma and requirement of mechanical ventilation were important risk factors, similarly to the presence of inhalation trauma.
The diagnostics and therapy of mycotic infections represent a great challenge. Culture of mycotic infections is quite lengthy. Since prompt diagnostics is currently greatly emphasized, the methods that demonstrate mycotic antigens are preferred more often, not only in burn patients. Mycotic antigens are actually parts of the body of the fungi, which can be demonstrated in various materials (blood, bronchoalveolar lavage and other). The most frequently used antigens today, which we encounter in common practice, include galactomannan for detection of aspergillum infection and also 1,3-β-D glucan as a so-called panfungal antigen in several fungi.13
Early diagnostics of zygomycetes infections is still problematic. Rising incidence has been observed recently also in these fibrous fungi. In relation with zygomycetes, Absidia species, Mucor species, Rhizomucor species and Rhizopus species occur in burn patients.14 Area after necrectomy in left lower limb with isolation of Absidia species is shown on Figure 2.
CONCLUSION
Immune paralysis or immunosuppression can develop in patients with thermal trauma, especially in case the extent of the burn is over 20% TBSA. This fact together with compromised local skin barrier and presence of other risk factors (inhalation trauma, mechanical ventilation and other) cause that the burn patients are susceptible for development of infectious complications caused by micromycetes.
Corresponding author:
Břetislav Lipový, M.D., Ph.D.
Department of Burns and Reconstructive Surgery,
University Hospital Brno
Jihlavská 20,
625 00 Brno
Czech Republic
E-mail: bretalipovy@gmail.com
Zdroje
1. Glik J, Kawecki M, Gaździk T, Nowak M. The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis. Pol Przegl Chir. 2012 Jan;84(1):6–16.
2. Lipový B et al. Prevalence of infectious complications in burn patients requiring intensive care: data from a pan-European study. Epidemiol Mikrobiol Imunol. 2016 Mar;65(1):25–32.
3. Lipový B et al. Unsuccessful therapy of combined mycotic infection in a severely burned patient: a case study. Acta Chir Plast. 2009;51(3–4):83–4.
4. Cochran A, Morris SE, Edelman LS, Saffle JR. Systemic Candida infection in burn patients: a case-control study of management patterns and outcomes. Surg Infect (Larchmt). 2002 Winter;3(4):367–74.
5. Tobiasen J, Hiebert JM, Edlich RF. The abbreviated burn severity index. Ann Emerg Med. 1982 May;11(5):260–2.
6. Nash G, Foley FD, Goodwin MN Jr, Bruck HM, Greenwald KA, Pruitt BA Jr. Fungal burn wound infection. JAMA. 1971 Mar 8;215(10):1664–6.
7. Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect. 2003 Jan;53(1):6–13.
8. Nasser S, Mabrouk A, Maher A. Colonization of burn wounds in Ain Shams University Burn Unit. Burns. 2003 May;29(3):229–33.
9. Ballard J et al.; Multicenter Trials Group, American Burn Association. Positive fungal cultures in burn patients: a multicenter review. J Burn Care Res. 2008 Jan-Feb;29(1):213–21.
10. Becker WK et al. Fungal burn wound infection. A 10-year experience. Arch Surg. 1991 Jan;126(1):44–8.
11. Mousa HA. Fungal infection of burn wounds in patients with open and occlusive treatment methods. East Mediterr Health J. 1999 Mar;5(2):333–6.
12. apoor MR, Sarabahi S, Tiwari VK, Narayanan RP. Fungal infections in burns: Diagnosis and management. Indian J Plast Surg. 2010 Sep;43(Suppl):S37–42.
13. Ráčil Z et al. Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results. Klin Mikrobiol Infekc Lek. 2009 Apr;15(2):48–57.
14. Piazza RC, Thomas WL, Stawski WS, Ford RD. Mucormycosis of the face. J Burn Care Res. 2009 May–Jun;30(3):520–3.
Štítky
Plastic surgery Orthopaedics Burns medicine TraumatologyČlánok vyšiel v časopise
Acta chirurgiae plasticae
2017 Číslo 1
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
Najčítanejšie v tomto čísle
- MEEK MICROGRAFTING TECHNIQUE AND ITS USE IN THE TREATMENT OF SEVERE BURN INJURIES AT THE UNIVERSITY HOSPITAL OSTRAVA BURN CENTER
- History, Present State and Perspectives of Czech Burns Medicine.
- OUR EXPERIENCE WITH THE USE OF 40% BENZOIC ACID FOR NECRECTOMY IN DEEP BURNS
- MICRONEEDLING – A FORM OF COLLAGEN INDUCTION THERAPY – OUR FIRST EXPERIENCES